PRMA Consulting - Building a healthier Asia

C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

FUJIFILM Diosynth Biotechnologies Opens New Biopharmaceutical CDMO Facility In North America

Introduction:

FUJIFILM Diosynth Biotechnologies plans for the construction of largest cell culture biophramaceutical CDMO facility. The facility will be located in North America.

Features:

The new, state-of-the-art facility consists of large-scale cell culture manufacturing of bulk drug substance production with 8 x 20,000L bioreactors.

This facility having the potential to expand will add further 24 x 20,000L bioreactors. Moreover, it expands and further add  24 x 20,000L bioreactors.

The new biopharmaceutical facility also consists of automated fill-finish, commercial-scale, packaging and labelling services. In addition, the new facility will have the ability to produce life-impacting medicines.

The new facility is expected to be completed and fully opeartional by spring 2025. Once the construction is completed it is expected to create 725 new jobs.

Specifications:

Name FUJIFILM Diosynth Biotechnologies
Type New Construction
Year 2025
Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEA SGS - ADVANCED ANALYTICS INTERPHEX 2023 Thermo Fisher Scientific - Gibco solutions ACG - Barrier Packaging